{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:32:13Z","timestamp":1772166733761,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH\/NCI Cancer Center Support","award":["Grant P30 CA008748"],"award-info":[{"award-number":["Grant P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer patients with pelviabdominal masses can suffer from lower extremity symptoms due to venous compression. The effectiveness of venous stenting has been established in extrinsic venous compression in benign conditions like May-Thurner syndrome. In this retrospective study we evaluate the efficacy and safety of caval, iliocaval and iliofemoral venous stenting for cases of extrinsic venous compression caused by malignant masses in cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>IRB-approved retrospective review of patients who underwent iliofemoral venography with venoplasty and stenting between January 2018 and February 2022 was performed. Patients with extrinsic venous compression caused by malignant masses were included. Data on patient demographics, pre-procedure symptoms, procedural technique, stent characteristics, outcomes and follow-up were collected. Descriptive statistics were used to assess technical success, clinical success, primary stent patency and adverse events of the procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-seven patients (19 males, 18 females) who underwent 45 procedures were included. Deep venous thrombosis (DVT) was present in 21 (57%) patients.\u00a0Twenty-nine patients (78%, 95% CI 62\u201390%) reported clinical improvement of the presenting symptoms. The median overall survival after the procedure was 4.7 months (95% CI 3.58\u20135.99). Eight (22%) patients were alive at last follow up with median follow up of 10.33 months (Range 2\u201325 months). Twenty-six patients had patent stents on their last follow up imaging (70%, 95% CI 61%-91%). Two patients had a small access site hematoma which resolved spontaneously. Two patients developed moderate, and 1 patient developed severe adverse events related to post procedure therapeutic anticoagulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Venous stenting is a safe procedure and should be considered as part of the palliative care for patients with debilitating lower extremity symptoms related to iliocaval and iliofemoral venous compression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s42155-024-00438-6","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T02:42:18Z","timestamp":1711075338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression"],"prefix":"10.1186","volume":"7","author":[{"given":"Ahmed K.","family":"Aly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amgad M.","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirish","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Petre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adie","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Bryce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2582-464X","authenticated-orcid":false,"given":"Fourat","family":"Ridouani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"issue":"5","key":"438_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1634\/theoncologist.2016-0246","volume":"22","author":"CA Cella","year":"2017","unstructured":"Cella CA, Di Minno G, Carlomagno C, et al. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: the ONKOTEV Study. Oncologist. 2017;22(5):601\u20138. https:\/\/doi.org\/10.1634\/theoncologist.2016-0246.","journal-title":"Oncologist."},{"issue":"3","key":"438_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1148\/rg.2020190097","volume":"40","author":"MC Olson","year":"2020","unstructured":"Olson MC, Lubner MG, Menias CO, et al. Venous thrombosis and hypercoagulability in the abdomen and pelvis: causes and imaging findings. Radiographics. 2020;40(3):875\u201394. https:\/\/doi.org\/10.1148\/rg.2020190097.","journal-title":"Radiographics."},{"issue":"6","key":"438_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715\u201322. https:\/\/doi.org\/10.1001\/jama.293.6.715.","journal-title":"JAMA"},{"issue":"1","key":"438_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42155-018-0024-2","volume":"1","author":"B Taslakian","year":"2018","unstructured":"Taslakian B, Koneru V, Sista AK. Endovascular iliac vein reconstruction through an obstructive pelvic nodal recurrence of urothelial carcinoma. CVIR Endovasc. 2018;1(1):16. https:\/\/doi.org\/10.1186\/s42155-018-0024-2.","journal-title":"CVIR Endovasc"},{"issue":"4","key":"438_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/0284185115582059","volume":"57","author":"G Maleux","year":"2016","unstructured":"Maleux G, Vertenten B, Laenen A, et al. Palliative endovascular treatment of cancer-related iliocaval obstructive disease: technical and clinical outcomes. Acta Radiol. 2016;57(4):451\u20136. https:\/\/doi.org\/10.1177\/0284185115582059.","journal-title":"Acta Radiol"},{"issue":"6","key":"438_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/13645700500381362","volume":"14","author":"Y Hama","year":"2005","unstructured":"Hama Y, Kaji T, Hayakawa M, Kosuda S. Endovascular stent placement for malignant stenosis and occlusion of the bilateral iliac veins and inferior vena cava after failure of radiation therapy. Minim Invasive Ther Allied Technol. 2005;14(6):372\u20135. https:\/\/doi.org\/10.1080\/13645700500381362.","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"1","key":"438_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jvir.2014.10.010","volume":"26","author":"GJ O'Sullivan","year":"2015","unstructured":"O\u2019Sullivan GJ, Waldron D, Mannion E, Keane M, Donnellan PP. Thrombolysis and iliofemoral vein stent placement in cancer patients with lower extremity swelling attributed to lymphedema. J Vasc Interv Radiol. 2015;26(1):39\u201345. https:\/\/doi.org\/10.1016\/j.jvir.2014.10.010.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"438_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.34172\/jcvtr.2020.57","volume":"13","author":"N Tadayon","year":"2021","unstructured":"Tadayon N, Zarrintan S, Hosseini SM, Kalantar-Motamedi SMR. Iliac vein stenting in a patient with lower extremity swelling resulting from diffuse pelvic mass: a case report. J Cardiovasc Thorac Res. 2021;13(1):84\u20136. https:\/\/doi.org\/10.34172\/jcvtr.2020.57.","journal-title":"J Cardiovasc Thorac Res"},{"issue":"7","key":"438_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1538574420939747","volume":"54","author":"B Wu","year":"2020","unstructured":"Wu B, Yin G, He X, et al. Endovascular treatment of cancer-associated venous obstruction: comparison of efficacy between stent alone and stent combined with linear radioactive seeds strand. Vasc Endovascular Surg. 2020;54(7):565\u201372. https:\/\/doi.org\/10.1177\/1538574420939747.","journal-title":"Vasc Endovascular Surg"},{"issue":"2","key":"438_CR10","first-page":"255","volume":"54","author":"GJ O'Sullivan","year":"2013","unstructured":"O\u2019Sullivan GJ, Sheehan J, Lohan D, McCann-Brown JA. Iliofemoral venous stenting extending into the femoral region: initial clinical experience with the purpose-designed Zilver Vena stent. J Cardiovasc Surg (Torino). 2013;54(2):255\u201361.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"3","key":"438_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00270-010-9927-6","volume":"34","author":"A Gutzeit","year":"2011","unstructured":"Gutzeit A, Zollikofer CL, Dettling-Pizzolato M, Graf N, Largiad\u00e8r J, Binkert CA. Endovascular stent treatment for symptomatic benign iliofemoral venous occlusive disease: long-term results 1987\u20132009. Cardiovasc Intervent Radiol. 2011;34(3):542\u20139. https:\/\/doi.org\/10.1007\/s00270-010-9927-6.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"438_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejvs.2010.04.016","volume":"40","author":"A Rosales","year":"2010","unstructured":"Rosales A, Sandbaek G, J\u00f8rgensen JJ. Stenting for chronic post-thrombotic vena cava and iliofemoral venous occlusions: mid-term patency and clinical outcome. Eur J Vasc Endovasc Surg. 2010;40(2):234\u201340. https:\/\/doi.org\/10.1016\/j.ejvs.2010.04.016.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"438_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jdmv.2021.02.004","volume":"46","author":"MC Montes","year":"2021","unstructured":"Montes MC, Carbonell JP, G\u00f3mez-Mesa JE. Endovascular and medical therapy of May-Thurner syndrome: case series and scoping literature review. J Med Vasc. 2021;46(2):80\u20139. https:\/\/doi.org\/10.1016\/j.jdmv.2021.02.004.","journal-title":"J Med Vasc"},{"issue":"3","key":"438_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ejvs.2009.09.028","volume":"39","author":"P H\u00f6lper","year":"2010","unstructured":"H\u00f6lper P, Kotelis D, Attigah N, Hyhlik-D\u00fcrr A, B\u00f6ckler D. Longterm results after surgical thrombectomy and simultaneous stenting for symptomatic iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg. 2010;39(3):349\u201355. https:\/\/doi.org\/10.1016\/j.ejvs.2009.09.028.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"438_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jvsv.2018.07.016","volume":"7","author":"PJ Gagne","year":"2019","unstructured":"Gagne PJ, Gagne N, Kucher T, Thompson M, Bentley D. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2019;7(1):45\u201355. https:\/\/doi.org\/10.1016\/j.jvsv.2018.07.016.","journal-title":"J Vasc Surg Venous Lymphat Disord."},{"issue":"1","key":"438_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jvsv.2019.08.015","volume":"8","author":"ZF Williams","year":"2020","unstructured":"Williams ZF, Dillavou ED. A systematic review of venous stents for iliac and venacaval occlusive disease. J Vasc Surg Venous Lymphat Disord. 2020;8(1):145\u201353. https:\/\/doi.org\/10.1016\/j.jvsv.2019.08.015.","journal-title":"J Vasc Surg Venous Lymphat Disord."},{"issue":"28","key":"438_CR17","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.2217\/fon-2017-0737","volume":"14","author":"AM Ierardi","year":"2018","unstructured":"Ierardi AM, Jannone ML, Petrillo M, et al. Treatment of venous stenosis in oncologic patients. Future Oncol. 2018;14(28):2933\u201343. https:\/\/doi.org\/10.2217\/fon-2017-0737.","journal-title":"Future Oncol"},{"issue":"10","key":"438_CR18","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jvir.2017.06.019","volume":"28","author":"O Khalilzadeh","year":"2017","unstructured":"Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol. 2017;28(10):1432-1437.e3. https:\/\/doi.org\/10.1016\/j.jvir.2017.06.019.","journal-title":"J Vasc Interv Radiol"},{"issue":"28","key":"438_CR19","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.jvir.2016.12.866","volume":"2","author":"R Perez-Johnston","year":"2017","unstructured":"Perez-Johnston R, Siegelbaum R, Muallem N, Boas F, Durack J. Endovascular stenting for symptomatic pelvic venous thrombosis or occlusion in cancer patients. J Vasc Interv Radiol. 2017;2(28):S112.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"438_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3892\/etm.2012.589","volume":"4","author":"L Xiao","year":"2012","unstructured":"Xiao L, Tong JJ, Shen J. Endoluminal treatment for venous vascular complications of malignant tumors. Exp Ther Med. 2012;4(2):323\u20138. https:\/\/doi.org\/10.3892\/etm.2012.589.","journal-title":"Exp Ther Med"},{"issue":"8","key":"438_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jvir.2012.04.019","volume":"23","author":"AK Kurklinsky","year":"2012","unstructured":"Kurklinsky AK, Bjarnason H, Friese JL, et al. Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience. J Vasc Interv Radiol. 2012;23(8):1009\u201315. https:\/\/doi.org\/10.1016\/j.jvir.2012.04.019.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"438_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jvsv.2018.02.004","volume":"6","author":"SA Rizvi","year":"2018","unstructured":"Rizvi SA, Ascher E, Hingorani A, Marks N. Stent patency in patients with advanced chronic venous disease and nonthrombotic iliac vein lesions. J Vasc Surg Venous Lymphat Disord. 2018;6(4):457\u201363. https:\/\/doi.org\/10.1016\/j.jvsv.2018.02.004.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"1","key":"438_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jvsv.2020.08.004","volume":"9","author":"MJ Drabkin","year":"2021","unstructured":"Drabkin MJ, Bajwa R, Perez-Johnston R, et al. Anticoagulation reduces iliocaval and iliofemoral stent thrombosis in patients with cancer stented for nonthrombotic venous obstruction. J Vasc Surg Venous Lymphat Disord. 2021;9(1):88\u201394. https:\/\/doi.org\/10.1016\/j.jvsv.2020.08.004.","journal-title":"J Vasc Surg Venous Lymphat Disord."},{"issue":"1","key":"438_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1148\/radiology.200.1.8657909","volume":"200","author":"GK Nazarian","year":"1996","unstructured":"Nazarian GK, Bjarnason H, Dietz CA, Bernadas CA, Hunter DW. Iliofemoral venous stenoses: effectiveness of treatment with metallic endovascular stents. Radiology. 1996;200(1):193\u20139. https:\/\/doi.org\/10.1148\/radiology.200.1.8657909.","journal-title":"Radiology"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-024-00438-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-024-00438-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-024-00438-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T02:43:46Z","timestamp":1711075426000},"score":1,"resource":{"primary":{"URL":"https:\/\/CVIRendovasc.springeropen.com\/articles\/10.1186\/s42155-024-00438-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["438"],"URL":"https:\/\/doi.org\/10.1186\/s42155-024-00438-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3588250\/v1","asserted-by":"object"}]},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"20 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}